Cargando…
A Risk Model for Predicting Fetuses with Trisomy 21 Using Alpha-Fetoprotein Variants L2 Combined with Maternal Serum Biomarkers in Early Pregnancy
To establish a risk prediction model and the clinical value of trisomy 21 using alpha-fetoprotein variants L2 (AFP-L2) combined with maternal serum biomarkers and nuchal translucency (NT) thickness in early pregnancy. A retrospective case–control study was conducted. The subjects were divided into t...
Autores principales: | Chen, Yiming, Wu, Bin, Chen, Yijie, Ning, Wenwen, Zhang, Huimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907085/ https://www.ncbi.nlm.nih.gov/pubmed/34750768 http://dx.doi.org/10.1007/s43032-021-00762-5 |
Ejemplares similares
-
Diagnostic value of maternal alpha-fetoprotein variants in second-trimester biochemical screening for trisomy 21 and 18
por: Chen, Yiming, et al.
Publicado: (2022) -
Aberrant right subclavian artery as soft marker in the diagnosis of trisomy 21 during the first trimester of pregnancy
por: Martínez-Payo, Cristina, et al.
Publicado: (2021) -
Fetal profile in fetuses with open spina bifida
por: Prodan, Natalia, et al.
Publicado: (2020) -
The importance of the cerebroplacental ratio for the prognosis of neonatal outcome in AGA fetuses
por: Mecke, L., et al.
Publicado: (2022) -
Prenatal ultrasound in fetuses with polycystic kidney appearance — expanding the diagnostic algorithm
por: Simonini, Corinna, et al.
Publicado: (2022)